These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19663790)

  • 21. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
    Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
    Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.
    Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL
    Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
    Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
    J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.
    Brizzolara A; Benelli R; Venè R; Barboro P; Poggi A; Tosetti F; Ferrari N
    Cancer Lett; 2017 Aug; 400():9-17. PubMed ID: 28450158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.
    Nakamura K; Yasunaga Y; Segawa T; Ko D; Moul JW; Srivastava S; Rhim JS
    Int J Oncol; 2002 Oct; 21(4):825-30. PubMed ID: 12239622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
    Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands.
    Shibata N; Nagai K; Morita Y; Ujikawa O; Ohoka N; Hattori T; Koyama R; Sano O; Imaeda Y; Nara H; Cho N; Naito M
    J Med Chem; 2018 Jan; 61(2):543-575. PubMed ID: 28594553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
    Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells.
    Verma V; Sharma V; Singh V; Sharma S; Bishnoi AK; Chandra V; Maikhuri JP; Dwivedi A; Kumar A; Gupta G
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):323-34. PubMed ID: 25123791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling.
    Tian H; Chou FJ; Tian J; Zhang Y; You B; Huang CP; Yeh S; Niu Y; Chang C
    J Exp Clin Cancer Res; 2021 Jan; 40(1):3. PubMed ID: 33390173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
    Chatterjee B
    Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells.
    Piccolella M; Crippa V; Messi E; Tetel MJ; Poletti A
    Pharmacol Res; 2014 Jan; 79():13-20. PubMed ID: 24184124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial androgen receptor targeted therapy for prostate cancer.
    Singh P; Uzgare A; Litvinov I; Denmeade SR; Isaacs JT
    Endocr Relat Cancer; 2006 Sep; 13(3):653-66. PubMed ID: 16954423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of the expression of prostate specific antigen by curcumin].
    Yang L; Zhang LY; Chen WW; Kong F; Zhang PJ; Hu XY; Zhang JY; Cui FA
    Yao Xue Xue Bao; 2005 Sep; 40(9):800-3. PubMed ID: 16342680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
    Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
    Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
    Roell D; Baniahmad A
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):1-8. PubMed ID: 20965230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer.
    Capitosti SM; Hansen TP; Brown ML
    Bioorg Med Chem; 2004 Jan; 12(2):327-36. PubMed ID: 14723953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.